Heterocyclic Thrombin Inhibitors. Part 1. Design and Synthesis of Amidino‐Phenoxy Quinoline Derivatives.
Uwe J. Ries(Boehringer Ingelheim (Germany)), Herbert Nar(Boehringer Ingelheim (Germany)), Henning Priepke(Boehringer Ingelheim (Germany)), Eric Haaksma, Norbert Hauel(Boehringer Ingelheim (Germany)), Jean Marie Stassen(Boehringer Ingelheim (Germany)), Wolfgang Wienen(Pharmazeutische Fabrik Dr. Reckeweg (Germany))
Cited by 0
Related Papers
Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5·5 and pH 9·0
|Journal of Molecular Biology|1991|487
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
|Journal of Medicinal Chemistry|2002|454
Biophysics in drug discovery: impact, challenges and opportunities
|Nature Reviews Drug Discovery|2016|383
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226
|European Journal of Pharmacology|1994|374